Aerovate Therapeutics Stock Alpha and Beta Analysis
| AVTE Stock | USD 2.61 0.05 1.88% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Aerovate Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Aerovate Therapeutics over a specified time horizon. Remember, high Aerovate Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Aerovate Therapeutics' market risk premium analysis include:
Beta 1.03 | Alpha 0.45 | Risk 3.66 | Sharpe Ratio 0.14 | Expected Return 0.52 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Aerovate |
Aerovate Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Aerovate Therapeutics market risk premium is the additional return an investor will receive from holding Aerovate Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Aerovate Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Aerovate Therapeutics' performance over market.| α | 0.45 | β | 1.03 |
Aerovate Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Aerovate Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Aerovate Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Aerovate Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Aerovate Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Aerovate Therapeutics shares will generate the highest return on investment. By understating and applying Aerovate Therapeutics stock market price indicators, traders can identify Aerovate Therapeutics position entry and exit signals to maximize returns.
Aerovate Therapeutics Return and Market Media
The median price of Aerovate Therapeutics for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 2.08 with a coefficient of variation of 13.83. The daily time series for the period is distributed with a sample standard deviation of 0.3, arithmetic mean of 2.18, and mean deviation of 0.25. The Stock received some media coverage during the period. Price Growth (%) |
| Timeline |
1 | Disposition of 2016 shares by George Eldridge of Aerovate Therapeutics at 2.14 subject to Rule 16b-3 | 09/05/2024 |
2 | Aerovate Therapeutics, Inc. Short Interest Up 9.5 percent in August | 09/17/2024 |
3 | Disposition of 6387 shares by Gillies Hunter of Aerovate Therapeutics at 25.8137 subject to Rule 16b-3 | 09/18/2024 |
4 | Disposition of 503 shares by Gillies Hunter of Aerovate Therapeutics at 1.74 subject to Rule 16b-3 | 10/24/2024 |
5 | Shareholder Alert Ademi LLP Investigates Whether Aerovate Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders | 10/31/2024 |
About Aerovate Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Aerovate or other stocks. Alpha measures the amount that position in Aerovate Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 68.37 | 16.9 | 7.04 | 6.69 | Net Debt To EBITDA | 2.33 | 0.4 | 0.28 | 0.27 |
Aerovate Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Aerovate Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aerovate Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Aerovate Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Aerovate Therapeutics. Please utilize our Beneish M Score to check the likelihood of Aerovate Therapeutics' management manipulating its earnings.
| 3rd of April 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 3rd of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Aerovate Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Aerovate Therapeutics Backtesting, Aerovate Therapeutics Valuation, Aerovate Therapeutics Correlation, Aerovate Therapeutics Hype Analysis, Aerovate Therapeutics Volatility, Aerovate Therapeutics History and analyze Aerovate Therapeutics Performance. For information on how to trade Aerovate Stock refer to our How to Trade Aerovate Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Aerovate Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.